glp 1 psychiatry Glucagon-like peptide-1 medicines in neurological and psychiatric disorders GLP-1 drugs' complex link to
Description
doi: 10.1016/j.brainres.2023.148693 5 BaruaR
The scope of this expert opinion is to aid in clinical decision-making for the appropriate use of the SGLT-2i and DPP-4i FDCs in T2DM management
Is there any relief on the horizon
J., Dale, I
The long-term outlook for patients affected by drug-induced NAION varies
